| Q91440678 | A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice |
| Q38672711 | A novel combination adjuvant platform for human and animal vaccines. |
| Q27312129 | A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models |
| Q40512544 | A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus |
| Q92517719 | A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus |
| Q33853324 | Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo |
| Q38919640 | CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells i |
| Q40552724 | Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity. |
| Q40703021 | Immune responses to Mycoplasma bovis proteins formulated with different adjuvants |
| Q33757880 | Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance |
| Q37001755 | In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant. |
| Q47593655 | Induction of a balanced IgG1/IgG2 immune response to an experimental challenge with Mycoplasma bovis antigens following a vaccine composed of Emulsigen™, IDR peptide1002, and poly I:C. |
| Q89514925 | Innate immunemodulator containing adjuvant formulated HA based vaccine protects mice from lethal infection of highly pathogenic avian influenza H5N1 virus |
| Q40076730 | Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus |
| Q40483231 | Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice |
| Q40096268 | Intrauterine delivery of subunit vaccines induces a systemic and mucosal immune response in rabbits. |
| Q38773273 | Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle. |
| Q38617302 | Recent advances in the development of subunit-based RSV vaccines. |
| Q35070505 | Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease |
| Q35070176 | Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease |
| Q41630664 | The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle |
| Q41511965 | The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies |
| Q51737656 | The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages. |
| Q55472927 | Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein. |
| Q45324627 | Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity |